Clinical trial
A Phase 2 Study of Colesevelam for Lenalidomide-Associated Diarrhea
NCT03767257 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study of Colesevelam for Lenalidomide-Associated Diarrhea
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 3, 2018
- Completion date
- November 27, 2024
- Enrollment
- 25 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.